Reviewing Cutera (CUTR) and Its Rivals

Cutera (NASDAQ: CUTR) is one of 46 public companies in the “Electromedical equipment” industry, but how does it weigh in compared to its peers? We will compare Cutera to related businesses based on the strength of its dividends, profitability, valuation, risk, earnings, analyst recommendations and institutional ownership.

Analyst Ratings

How to Become a New Pot Stock Millionaire

This is a breakdown of recent ratings and target prices for Cutera and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cutera 0 1 4 0 2.80
Cutera Competitors 147 434 967 26 2.55

Cutera presently has a consensus target price of $43.00, indicating a potential downside of 16.34%. As a group, “Electromedical equipment” companies have a potential upside of 25.38%. Given Cutera’s peers higher probable upside, analysts clearly believe Cutera has less favorable growth aspects than its peers.

Volatility and Risk

Cutera has a beta of 0.45, indicating that its stock price is 55% less volatile than the S&P 500. Comparatively, Cutera’s peers have a beta of 1.58, indicating that their average stock price is 58% more volatile than the S&P 500.

Institutional and Insider Ownership

95.3% of Cutera shares are held by institutional investors. Comparatively, 41.1% of shares of all “Electromedical equipment” companies are held by institutional investors. 11.6% of Cutera shares are held by company insiders. Comparatively, 20.1% of shares of all “Electromedical equipment” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Cutera and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cutera 19.80% 18.31% 11.39%
Cutera Competitors -207.45% 32.88% -13.47%

Earnings and Valuation

This table compares Cutera and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Cutera $151.49 million $29.99 million 66.75
Cutera Competitors $1.10 billion $121.39 million -37.94

Cutera’s peers have higher revenue and earnings than Cutera. Cutera is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Summary

Cutera peers beat Cutera on 7 of the 13 factors compared.

About Cutera

Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; solera console platform, including Opus and Titan consoles; and CoolGlide systems, as well as provides myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; skin care products; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply